{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:11:00Z","timestamp":1782756660325,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40256-024-00633-9","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T12:02:01Z","timestamp":1709121721000},"page":"273-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-8626","authenticated-orcid":false,"given":"Ahmed Kamal","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Maniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Tanveer","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"633_CR1","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/circ.131.suppl_2.o29","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322.","journal-title":"Circulation"},{"issue":"9","key":"633_CR2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics\u20132020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139\u2013596. https:\/\/doi.org\/10.1161\/CIR.0000000000000757.","journal-title":"Circulation"},{"issue":"8","key":"633_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ejhf.567","volume":"18","author":"M Christ","year":"2016","unstructured":"Christ M, St\u00f6rk S, D\u00f6rr M, Heppner HJ, M\u00fcller C, Wachter R, Riemer U, Trend HF Germany Project. Heart failure epidemiology 2000\u20132013: insights from the German Federal Health Monitoring System. Eur J Heart Fail. 2016;18(8):1009\u201318. https:\/\/doi.org\/10.1002\/ejhf.567. (Epub 2016 Jun 1. PMID: 27246139).","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"633_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, Tang WHW, Droogn\u00e9 W, Mullens W. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019;21(11):1415\u201322. https:\/\/doi.org\/10.1002\/ejhf.1478. (Epub 2019 May 9 PMID: 31074184).","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"633_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M, ADVOR Study Group. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022;387(13):1185\u201395. https:\/\/doi.org\/10.1056\/NEJMoa2203094. (Epub 2022 Aug 27. PMID: 36027559).","journal-title":"N Engl J Med"},{"key":"633_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/CRD.0000000000000116","volume":"24","author":"BN Bowman","year":"2016","unstructured":"Bowman BN, Nawarskas JJ, Anderson JR. Treating diuretic resistance: an overview. Cardiol Rev. 2016;24:256\u201360. https:\/\/doi.org\/10.1097\/CRD.0000000000000116.","journal-title":"Cardiol Rev"},{"key":"633_CR7","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16526","author":"A Kosiorek","year":"2023","unstructured":"Kosiorek A, Urban S, Detyna J, Biegus J, Hurkacz M, Zymli\u0144ski R. The diuretic, natriuretic and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload. A single center, prospective, randomized study. Pol Arch Intern Med. 2023. https:\/\/doi.org\/10.20452\/pamw.16526. (Epub ahead of print. PMID: 37415505).","journal-title":"Pol Arch Intern Med"},{"key":"633_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"633_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","volume":"5","author":"M Metra","year":"2012","unstructured":"Metra M, Davison B, Bettari L, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012;5:54\u201362.","journal-title":"Circ Heart Fail"},{"key":"633_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion\u2014a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:137\u201355.","journal-title":"Eur J Heart Fail"},{"key":"633_CR11","first-page":"80","volume":"17","author":"H Kataoka","year":"2017","unstructured":"Kataoka H. Treatment of hypochloremia with acetazolamide in an advanced heart failure patient and importance of monitoring urinary electrolytes. J Cardiol. 2017;17:80\u20134.","journal-title":"J Cardiol"},{"key":"633_CR12","first-page":"209","volume":"50","author":"GR Herrmann","year":"1954","unstructured":"Herrmann GR, Baxter MR, Hejtmancik MR, Moran AR. Diamox: new oral nonmercurial, nontoxic diuretic for the treatment of congestive heart failure. Tex State J Med. 1954;50:209\u201313.","journal-title":"Tex State J Med"},{"key":"633_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJM195307232490404","volume":"249","author":"H Belsky","year":"1953","unstructured":"Belsky H. Use of a new oral diuretic, diamox, in congestive heart failure. N Engl J Med. 1953;249:140\u20133. https:\/\/doi.org\/10.1056\/NEJM195307232490404.","journal-title":"N Engl J Med"},{"key":"633_CR14","first-page":"381","volume":"45","author":"RM Suarez","year":"1953","unstructured":"Suarez RM, Suarez RM Jr, Buso R, Sabater J. Diamox; a new non-mercurial diuretic for oral administration; clinical observations on the treatment of edema due to cardiac failure. Bol Asoc Med PR. 1953;45:381\u20136.","journal-title":"Bol Asoc Med PR"},{"issue":"3","key":"633_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/ac.70.3.3080630","volume":"70","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Dupont M, Bertrand PB, Nijst P, Penders J, Dens J, Verhaert D, Vandervoort P, Tang WH, Mullens W. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol. 2015;70(3):265\u201373. https:\/\/doi.org\/10.1080\/ac.70.3.3080630. (PMID: 26226699).","journal-title":"Acta Cardiol"},{"issue":"4","key":"633_CR16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37792","volume":"15","author":"BA Malik","year":"2023","unstructured":"Malik BA, Nnodebe I, Fayaz A, et al. Effect of acetazolamide as add-on diuretic therapy in patients with heart failure: a meta-analysis. Cureus. 2023;15(4): e37792. https:\/\/doi.org\/10.7759\/cureus.37792. (Published 2023 Apr 18).","journal-title":"Cureus"},{"issue":"3","key":"633_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/jcm8030349","volume":"8","author":"J Wongboonsin","year":"2019","unstructured":"Wongboonsin J, Thongprayoon C, Bathini T, et al. Acetazolamide therapy in patients with heart failure: a meta-analysis. J Clin Med. 2019;8(3):349. https:\/\/doi.org\/10.3390\/jcm8030349. (Published 2019 Mar 12).","journal-title":"J Clin Med"},{"issue":"339","key":"633_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"21","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;21(339): b2700. https:\/\/doi.org\/10.1136\/bmj.b2700. (PMID:19622552; PMCID:PMC2714672).","journal-title":"BMJ"},{"issue":"366","key":"633_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366): l4898. https:\/\/doi.org\/10.1136\/bmj.l4898. (PMID: 31462531).","journal-title":"BMJ"},{"issue":"14","key":"633_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45.PMID:24690082;PMCID:PMC4021422","volume":"1","author":"CK Lo","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M. Newcastle\u2013Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;1(14):45. https:\/\/doi.org\/10.1186\/1471-2288-14-45.PMID:24690082;PMCID:PMC4021422.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"633_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2. (PMID: 3802833).","journal-title":"Control Clin Trials"},{"key":"633_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"issue":"7","key":"633_CR23","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.26355\/eurrev_202104_25550","volume":"25","author":"D Orso","year":"2021","unstructured":"Orso D, Tavazzi G, Corradi F, Mearelli F, Federici N, Peric D, D\u2019Andrea N, Santori G, Mojoli F, Forfori F, Vetrugno L, Bove T. Comparison of diuretic strategies in diuretic-resistant acute heart failure: a systematic review and network meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(7):2971\u201380. https:\/\/doi.org\/10.26355\/eurrev_202104_25550. (PMID: 33877660).","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"633_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","volume":"7","author":"JM Testani","year":"2014","unstructured":"Testani JM, Brisco MA, Turner JM, et al. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail. 2014;7:261\u201370.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"633_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.hfc.2019.08.010","volume":"16","author":"MR Costanzo","year":"2020","unstructured":"Costanzo MR. The cardiorenal syndrome in heart failure. Heart Fail Clin. 2020;16(1):81\u201397. https:\/\/doi.org\/10.1016\/j.hfc.2019.08.010. (PMID: 31735318).","journal-title":"Heart Fail Clin"},{"issue":"3","key":"633_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","volume":"12","author":"JM ter Maaten","year":"2015","unstructured":"ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12(3):184\u201392. https:\/\/doi.org\/10.1038\/nrcardio.2014.215. (Epub 2015 Jan 6 PMID: 25560378).","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"633_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/CNQ.0000000000000173","volume":"40","author":"BN Reed","year":"2017","unstructured":"Reed BN, Devabhakthuni S. Diuretic resistance in acute decompensated heart failure: a challenging clinical conundrum. Crit Care Nurs Q. 2017;40(4):363\u201373. https:\/\/doi.org\/10.1097\/CNQ.0000000000000173. (PMID: 28834858).","journal-title":"Crit Care Nurs Q"},{"issue":"1","key":"633_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2016.09.012","volume":"5","author":"AP Ambrosy","year":"2017","unstructured":"Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O\u2019Connor CM, Schulte P, Starling RC, Teerlink JR, Voors AA, Mentz RJ. Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes: findings from the ASCEND-HF Trial. JACC Heart Fail. 2017;5(1):1\u201313. https:\/\/doi.org\/10.1016\/j.jchf.2016.09.012. (PMID:28034373; PMCID:PMC5218831).","journal-title":"JACC Heart Fail"},{"issue":"9","key":"633_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O\u2019Connor CM, NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419. (PMID: 21366472; PMCID: PMC3412356).","journal-title":"N Engl J Med"},{"issue":"24","key":"633_CR30","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","volume":"367","author":"BA Bart","year":"2012","unstructured":"Bart BA, Goldsmith SR, Lee KL, Givertz MM, O\u2019Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E, Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296\u2013304. https:\/\/doi.org\/10.1056\/NEJMoa1210357. (Epub 2012 Nov 6. PMID: 23131078; PMCID: PMC3690472).","journal-title":"N Engl J Med"},{"issue":"1","key":"633_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1067\/mhj.2002.123144","volume":"144","author":"GW Neuberg","year":"2002","unstructured":"Neuberg GW, Miller AB, O\u2019Connor CM, Belkin RN, Carson PE, Cropp AB, Frid DJ, Nye RG, Pressler ML, Wertheimer JH, Packer M, PRAISE Investigators. Prospective Randomized Amlodipine Survival Evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J. 2002;144(1):31\u20138. https:\/\/doi.org\/10.1067\/mhj.2002.123144. (PMID: 12094185).","journal-title":"Am Heart J"},{"issue":"3\u20134","key":"633_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"DH Ellison","year":"2001","unstructured":"Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology. 2001;96(3\u20134):132\u201343. https:\/\/doi.org\/10.1159\/000047397. (PMID: 11805380).","journal-title":"Cardiology"},{"issue":"19","key":"633_CR33","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","volume":"35","author":"MA Valente","year":"2014","unstructured":"Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O\u2019Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35(19):1284\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehu065. (Epub 2014 Feb 28 PMID: 24585267).","journal-title":"Eur Heart J"},{"issue":"16","key":"633_CR34","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA, American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840\u201378. https:\/\/doi.org\/10.1161\/CIR.0000000000000664. (PMID: 30852913).","journal-title":"Circulation"},{"issue":"6","key":"633_CR35","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2019.18","volume":"28","author":"I Kristj\u00e1nsd\u00f3ttir","year":"2020","unstructured":"Kristj\u00e1nsd\u00f3ttir I, Thorvaldsen T, Lund LH. Congestion and diuretic resistance in acute or worsening heart failure. Card Fail Rev. 2020;28(6): e25. https:\/\/doi.org\/10.15420\/cfr.2019.18. (PMID:33042585; PMCID:PMC7539143).","journal-title":"Card Fail Rev"},{"issue":"1","key":"633_CR36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21369","volume":"14","author":"E Shams","year":"2022","unstructured":"Shams E, Bonnice S, Mayrovitz HN. Diuretic resistance associated with heart failure. Cureus. 2022;14(1): e21369. https:\/\/doi.org\/10.7759\/cureus.21369. (PMID:35198282; PMCID:PMC8852330).","journal-title":"Cureus."},{"issue":"5","key":"633_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","volume":"44","author":"JC Trulls","year":"2023","unstructured":"Trulls JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Snchez-Marteles M, Conde-Martel A, Dvila-Ramos MF, Llcer P, Salamanca-Bautista P, Prez-Silvestre J, Plasn MN, Cerqueiro JM, Gil P, Formiga F, Manzano L, CLOROTIC trial investigators. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J. 2023;44(5):411\u201321. https:\/\/doi.org\/10.1093\/eurheartj\/ehac689. (PMID: 36423214).","journal-title":"Eur Heart J"},{"issue":"3","key":"633_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","volume":"8","author":"ZL Cox","year":"2020","unstructured":"Cox ZL, Hung R, Lenihan DJ, Testani JM. Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial. JACC Heart Fail. 2020;8(3):157\u201368. https:\/\/doi.org\/10.1016\/j.jchf.2019.09.012.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"633_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/08998280.2020.1830332","volume":"34","author":"D Gill","year":"2020","unstructured":"Gill D, Gadela NV, Azmeen A, Jaiswal A. Usefulness of acetazolamide in the management of diuretic resistance. Proc (Bayl Univ Med Cent). 2020;34(1):169\u201371. https:\/\/doi.org\/10.1080\/08998280.2020.1830332. (Published 2020 Oct 16).","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"6","key":"633_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12465","volume":"36","author":"J N\u00fa\u00f1ez","year":"2018","unstructured":"N\u00fa\u00f1ez J, Heredia R, Pay\u00e1 A, Sanchis I, Del Prado S, Mi\u00f1ana G, Santas E, de la Espriella R, N\u00fa\u00f1ez E, Sanchis J, Bay\u00e9s-Gen\u00eds A. Use of acetazolamide in the treatment of patients with refractory congestive heart failure. Cardiovasc Ther. 2018;36(6): e12465. https:\/\/doi.org\/10.1111\/1755-5922.12465. (Epub 2018 Sep 29. PMID: 30191652).","journal-title":"Cardiovasc Ther"},{"key":"633_CR41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1159\/000354515","volume":"32","author":"Y An","year":"2013","unstructured":"An Y, Zhang JZ, Han J, Yang HP, Tie L, Yang XY, Xiaokaiti Y, Pan Y, Li XJ. Hypoxia-inducible factor-1alpha dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury. Cell Physiol Biochem. 2013;32:1151\u201366.","journal-title":"Cell Physiol Biochem"},{"key":"633_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079327","volume":"8","author":"K Zahedi","year":"2013","unstructured":"Zahedi K, Barone S, Xu J, Soleimani M. Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications. PLoS\u00a0One. 2013;8: e79327.","journal-title":"PLoS\u00a0One"},{"issue":"12","key":"633_CR43","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","volume":"37","author":"T Imiela","year":"2017","unstructured":"Imiela T, Budaj A. Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study. Clin Drug Investig. 2017;37(12):1175\u201381. https:\/\/doi.org\/10.1007\/s40261-017-0577-1.","journal-title":"Clin Drug Investig"},{"issue":"9","key":"633_CR44","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/ehjacc\/zuac108","volume":"11","author":"X Rossello","year":"2022","unstructured":"Rossello X, Menon V, Vranckx P. Acetazolamide for patients with acute decompensated heart failure with volume overload. Eur Heart J Acute Cardiovasc Care. 2022;11(9):712\u20133.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"11","key":"633_CR45","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/ejhf.1502","volume":"21","author":"P Javaloyes","year":"2019","unstructured":"Javaloyes P, Mir\u00f3 \u00d2, Gil V, Mart\u00edn-S\u00e1nchez FJ, Jacob J, Herrero P, et al. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail. 2019;21(11):1353\u201365.","journal-title":"Eur J Heart Fail"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00633-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:26:23Z","timestamp":1711556783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00633-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00633-9","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"29 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All data generated or analysed during this study are included in this published article (and its supplementary information files).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors participated in data curation, analysis, writing, reviewing and editing this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"A.P.A. is supported by a grant from the National Heart, Lung, and Blood Institute (K23HL150159), American Heart Association (no. 1155554), has received relevant research support through grants to his institution from Amarin Pharma, Inc., Abbott, and Novartis, and modest reimbursement for travel from Novartis. Dr. Greene has received research support from the Duke University Department of Medicine Chair\u2019s Research Award, American Heart Association (no. 929502), Amgen, AstraZeneca, Boehinger Ingelheim, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards or as consultant for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim\/ Lilly, Bristol Myers Squibb, Corteria Pharmaceuticals, CSL Vifor, Cytokinetics, Lexicon, Merck, Roche Diagnostics, Sanofi, scPharmaceuticals, Tricog Health, and Urovant Pharmaceuticals; and has received speaker fees from Boehringer Ingelheim, Cytokinetics, Lexicon, and Roche Diagnostics. M.F. is supported by the Mario Family Award,\u00a0Duke Chair\u2019s Award, Translating Duke Health Award, Bayer, and BTG Specialty Pharmaceuticals. He receives consulting fees from AxonTherapies, Bodyport, CVRx, Daxor, Edwards LifeSciences, Fire1, NXT Biomedical, Zoll, and Viscardia. S.J.G. has received research support from the Duke University Department of Medicine Chair\u2019s Research Award, American Heart Association (no. 929502), National Heart Lung and Blood Institute, Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards for Amgen, AstraZeneca, Boehringer Ingelheim\/ Lilly, Bristol Myers Squibb, Cytokinetics, Roche Diagnostics, Sanofi, and scPharmaceuticals; serves as a consultant for Amgen, Bayer, Bristol Myers Squibb, Boehringer Ingelheim\/ Lilly, CSL Vifor, Merck, PharmaIN, Roche Diagnostics, Sanofi, Tricog Health, and Urovant Pharmaceuticals; and has received speaker fees from Boehringer Ingelheim and Cytokinetics.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"N\/A.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N\/A.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}